NCT02938702 Active Surveillance on Papillary Thyroid Microcarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02911155 Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists Status COMPLETED Phase N/A
NCT02862470 Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients Status COMPLETED Phase N/A
NCT02731352 Study of Apatinib in Patients With Differentiated Thyroid Cancer Status COMPLETED Phase PHASE2
NCT02726282 Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey Status WITHDRAWN Phase N/A
NCT02724176 Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer Status COMPLETED Phase NA
NCT02702388 A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile Status COMPLETED Phase PHASE2
NCT02658513 Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer Status COMPLETED Phase N/A
NCT02657551 A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02628067 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02602717 The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study. Status UNKNOWN Phase NA
NCT02515084 Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma Status COMPLETED Phase PHASE2
NCT02472080 Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study Status TERMINATED Phase PHASE2
NCT02456701 Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 Status COMPLETED Phase PHASE1
NCT02408887 Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer Status TERMINATED Phase PHASE2